Scott MacKay
Papers
1
Total Citations
6
H-Index
1
About
Scott MacKay is a leading innovator in clinical mass spectrometry, with a focus on developing high-throughput, accessible platforms for disease screening. His most prominent contribution is the creation of the Open SprayBot, a paper spray mass spectrometry platform designed to revolutionize newborn metabolic screening. This work addresses a critical bottleneck in global healthcare: the need for rapid, cost-effective analysis of biofluids without complex handling or cold-chain transport. By demonstrating that high-quality metabolic data can be obtained from dried blood spots using ambient ionization, MacKay’s research directly improves survival rates and reduces treatment costs for healthcare systems. His 2024 paper on the Open SprayBot has already garnered significant attention, accumulating 6 citations in its first year—a strong indicator of its immediate impact. MacKay’s work bridges engineering and clinical chemistry, offering a scalable solution for resource-limited settings. His achievements underscore a commitment to translating fundamental mass spectrometry principles into practical, life-saving diagnostics, positioning him as a key figure in the next generation of point-of-care metabolic testing.
Research Focus
Key Achievements
Top Papers
- 1